普洛药业(000739) - 2016 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2016 was ¥984,114,689.58, a decrease of 5.21% compared to ¥1,038,255,285.69 in the same period last year[8] - Net profit attributable to shareholders was ¥37,750,156.62, down 21.47% from ¥48,073,899.38 year-on-year[8] - The net profit after deducting non-recurring gains and losses was ¥35,034,492.54, reflecting a decline of 26.10% compared to ¥47,407,686.39 in the previous year[8] - Basic and diluted earnings per share were both ¥0.0330, down 21.43% from ¥0.0420 in the previous year[8] - The net cash flow from operating activities was negative at -¥121,265,335.59, a significant decrease of 287.60% from ¥64,641,298.72 in the same period last year[8] Assets and Shareholder Information - Total assets at the end of the reporting period were ¥5,568,373,071.99, an increase of 3.21% from ¥5,394,938,741.45 at the end of the previous year[8] - Net assets attributable to shareholders increased by 1.56% to ¥2,454,441,186.84 from ¥2,416,691,030.22 at the end of the previous year[8] - The total number of ordinary shareholders at the end of the reporting period was 72,457[11] - The largest shareholder, Hengdian Group Holdings Co., Ltd., held 23.52% of the shares, amounting to 269,752,252 shares, with 74,380,165 shares pledged[11] Cash Flow and Expenses - Accounts receivable increased by 31.49% to 168,660,945.16 due to increased billings[15] - Prepayments surged by 159.20% to 100,907,808.99 primarily due to higher payments for materials and equipment[15] - Employee compensation payable decreased by 44.01% to 51,122,660.93 as a result of payments made for accrued compensation[15] - Financial expenses rose by 65.59% to 13,951,339.98 mainly due to increased interest expenses[15] - Tax refunds received increased by 49.63% to 38,652,778.90, attributed to higher export tax rebates[15] - Cash received from borrowings increased by 45.52% to 479,092,500.00 due to more borrowings in the current period[15] - Cash paid for dividends and interest increased by 50.29% to 16,658,816.35, reflecting higher interest payments[15] - Cash paid for other investment activities decreased by 88.01% to 1,186,200.00, as last period had significant fixed asset investment payments[15] Corporate Governance - The company did not engage in any repurchase transactions during the reporting period[12] - The company has ongoing commitments to maintain independence and avoid competition with its controlling shareholder[16] Future Outlook - There were no significant changes in the company's operational performance expected for the first half of 2016[19]